Inhibrx Biosciences, Inc. · NASDAQ:INBX
Inhibrx Biosciences, Inc. shareholders
As of Jun 30, 2026, 157 institutions reported holding Inhibrx Biosciences, Inc., 97.4% of its shares. Largest: Morgan Stanley, Perceptive Advisors LLC and Sanofi. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Inhibrx Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Morgan Stanley | 1.31M | 8.9% | +44,973 | Aug 13, 2026 |
| Perceptive Advisors LLC | 1.3M | 8.8% | −145K | Aug 14, 2026 |
| Sanofi | 1.16M | 7.9% | no change | Jul 28, 2026 |
| Viking Global Investors LP | 1.12M | 7.6% | −314K | Aug 14, 2026 |
| HighTower Advisors, LLC | 871K | 5.9% | +351 | Aug 26, 2026 |
| Bank of America | 841K | 5.7% | +808K | Aug 14, 2026 |
| BlackRock | 826K | 5.6% | +27,074 | Aug 7, 2026 |
| Vanguard | 699K | 4.8% | +61,750 | Aug 13, 2026 |
| Schonfeld Strategic Advisors LLC | 698K | 4.7% | +443K | Aug 14, 2026 |
| State Street | 640K | 4.4% | +89,613 | Aug 7, 2026 |